Regulatory volatility creates a continuous compliance burden, where even minor shifts might trigger massive downstream updates to dossiers.
Biolevate turns this reactive cycle into a competitive edge: the platform automates the monitoring of fragmented frameworks, instantly assessing the impact on your portfolio to slash update cycles and prevent market disruptions
80% time reduction
Cut time spent on screening regulatory updates and downstream analysis by up to 80% with automated monitoring, change detection, and impact mapping.
Lower non‑compliance risk
Stay continuously aligned with the latest requirements by detecting changes early and triggering the right dossier updates before drift accumulates.
Faster time‑to‑market
Shorten regulatory update cycles across your portfolio so submissions and expansions move faster with fewer surprises and disruptions.
How it works
1
Continuously monitor regulatory sources - automatically refresh content from authorities and frameworks (e.g., EMA, FDA) to keep a governed, up-to-date regulatory knowledge base.
2
Detect changes and extract insights - identify what changed (new guidance, revised requirements, reclassifications) and structure the deltas into actionable insights.
3
Assess impact on your portfolio - map changes to products, classifications, and commitments to determine which dossiers, submissions, and processes are affected.
4
Trigger and prioritize downstream updates - generate a change-to-action plan (owners, impacted sections, suggested updates) to shorten update cycles and prevent compliance drift.
Always up-to-date regulatory content: automated monitoring and refresh of fragmented sources to maintain a single source of truth.
Change impact, not just change detection: link regulatory deltas to specific products/dossiers to focus effort where it matters.